Stay updated on M7824 and Topotecan in Relapsed SCLC Clinical Trial
Sign up to get notified when there's something new on the M7824 and Topotecan in Relapsed SCLC Clinical Trial page.

Latest updates to the M7824 and Topotecan in Relapsed SCLC Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe page has been updated to reflect that the study is now active and not recruiting, with a new actual date of 2025-03-06, replacing the previous estimated date of 2025-03-01.SummaryDifference2%
- Check23 days agoChange DetectedThe webpage has updated its date references, removing several past dates and adding new ones for March 2025.SummaryDifference0.8%
- Check30 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference0.9%
- Check45 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference0.9%
- Check52 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.1%
- Check66 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.1%
Stay in the know with updates to M7824 and Topotecan in Relapsed SCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the M7824 and Topotecan in Relapsed SCLC Clinical Trial page.